SEC Form 4 · accession 0001144204-15-006982
NAVIDEA BIOPHARMACEUTICALS, INC. · NAVB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael M Goldberg
Director
Period of report
Feb 5, 2015
Accepted (ET)
Feb 9, 2015 · 12:54 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000810509
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 5, 2015 | A | 6,614 | $1.89 | A | 296,325 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Acquired from the Issuer in lieu of cash compensation for board and committee service during 3Q 2014.